French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on June 29, 2026

30 minutes ago

George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations

Indeterminate GlobeNewswire

30 minutes ago

Dr. Mariusz Sapijaszko elected President of the Canadian Dermatology Association

Indeterminate GlobeNewswire

30 minutes ago

Le Dr Mariusz Sapijaszko élu président de l’Association canadienne de dermatologie

Indeterminate GlobeNewswire

30 minutes ago

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

30 minutes ago

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

30 minutes ago

Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET

Indeterminate GlobeNewswire

30 minutes ago

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

30 minutes ago

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Indeterminate GlobeNewswire

30 minutes ago

NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company

Indeterminate GlobeNewswire

30 minutes ago

BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility

Indeterminate GlobeNewswire

30 minutes ago

Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund

Indeterminate GlobeNewswire

30 minutes ago

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

Indeterminate GlobeNewswire

31 minutes ago

Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen

Indeterminate GlobeNewswire

an hour ago

Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

Indeterminate GlobeNewswire

2 hours ago

Zymeworks to Acquire Theravance Biopharma, Inc.

Indeterminate GlobeNewswire

3 hours ago

Resalis Announces Initiation of Phase 1b Clinical Study Evaluating RES-010 as Treatment to Address Unmet Needs in Obesity

Indeterminate GlobeNewswire

3 hours ago

ITM, Helmholtz Munich and the University of Münster Announce Updated Preliminary Phase 1 Data with ITM-31 in Glioblastoma Patients

Indeterminate GlobeNewswire

4 hours ago

TolerogenixX Completes Last Patient Transplant in Phase IIb TOL-2 Trial of MIC-Lx, Advancing a New Immune Tolerance Approach in Kidney Transplantation

Indeterminate GlobeNewswire

5 hours ago

Aplagon Appoints Carl Lindgren as Board Chair to Guide Later Stage Clinical and Corporate Development

Indeterminate GlobeNewswire

5 hours ago

Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations

Indeterminate GlobeNewswire